Icona Mibrance

1.0.5 by Pfizer Inc.


Jun 7, 2021

Informazioni su Mibrance

MIBRANCETM è uno strumento per i pazienti e i loro caregiver che gestiscono il trattamento

MIBRANCETM is a tool for patients and their caregivers managing treatment for metastatic breast cancer.

It enables the patient to keep track of his medication schedule and symptoms and create reminders for doctor’s appointments and blood testing. Designed for daily use, it gives the patient a place to record his feelings, log specific symptoms, and reminds him when to take his medication. The patient can also create reports that can be emailed and shared with caregivers and healthcare providers.

Features:

• Reminds you to take your medication

• Allows you to track your symptoms

• Enables you to create reports that can be emailed and shared with caregivers

• Allows you to keep track of your doctor and blood test appointments

• Offers tips and advice on managing symptoms

MIBRANCETM app is not meant to take the place of your doctor’s care or advice. Please contact him or her if you have any questions about your treatment. MIBRANCE TM app is not intended for curing, treating, or seeking treatment for managing or diagnosing a specific disease, disorder, or any specific identifiable health condition.

MIBRANCETM app is available in French, Dutch and English.

Novità nell'ultima versione 1.0.5

Last updated on Jun 7, 2021

Minor content change

Traduzione in caricamento...

Informazioni APP aggiuntive

Ultima versione

Richiedi aggiornamento Mibrance 1.0.5

Caricata da

Kirito Kazuto

È necessario Android

Android 6.0+

Mostra Altro

Mibrance Screenshot

Commento Loading...
Lingua
Ricerca...
Iscriviti ad APKPure
Sii il primo ad accedere alla versione anticipata, alle notizie e alle guide dei migliori giochi e app Android.
No grazie
Iscrizione
Abbonato con successo!
Ora sei iscritto ad APKPure.
Iscriviti ad APKPure
Sii il primo ad accedere alla versione anticipata, alle notizie e alle guide dei migliori giochi e app Android.
No grazie
Iscrizione
Successo!
Ora sei iscritto alla nostra newsletter.